Projected Income Statement: Ipsen

Forecast Balance Sheet: Ipsen

Forecast Balance Sheet - Ipsen
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 138 -385 -52.9 -135 -545 -1,260 -2,153 -3,126
Change - -378.99% 86.26% -155.2% -303.7% -131.4% -70.87% -45.19%
Announcement Date 11/02/22 09/02/23 08/02/24 13/02/25 12/02/26 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Ipsen

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 96 96.6 116.2 173 105.3 136.5 141 150.1
Change - 0.62% 20.29% 48.88% -39.13% 29.64% 3.25% 6.52%
Free Cash Flow (FCF) 1 813.2 874.8 710.9 774.4 1,033 1,206 1,229 1,244
Change - 7.58% -18.74% 8.93% 33.41% 16.73% 1.94% 1.22%
Announcement Date 11/02/22 09/02/23 08/02/24 13/02/25 12/02/26 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Ipsen

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 40.64% 44.57% 28.18% 35.28% 35.21% 41.95% 38.68% 36.81%
EBIT Margin (%) 35.25% 36.87% 32.01% 32.62% 32.94% 36.34% 32.5% 30.23%
EBT Margin (%) 28.39% 23.34% 24.35% 12.69% 14.73% 28.57% 28.07% 25.62%
Net margin (%) 22.54% 21.4% 20.69% 10.21% 11.31% 22.04% 21.74% 20.17%
FCF margin (%) 28.35% 28.92% 22.73% 22.77% 26.29% 26.27% 26.06% 25.5%
FCF / Net Income (%) 125.77% 135.1% 109.84% 222.98% 232.42% 119.21% 119.89% 126.44%

Profitability

        
ROA 13.88% 16.46% 12.83% 13.44% 15.09% 14.82% 13.12% 11.54%
ROE 26.49% 28.73% 21.36% 21.43% 23.69% 24.6% 19.85% 16.8%

Financial Health

        
Leverage (Debt/EBITDA) 0.12x - - - - - - -
Debt / Free cash flow 0.17x - - - - - - -

Capital Intensity

        
CAPEX / Current Assets (%) 3.35% 3.19% 3.72% 5.09% 2.68% 2.97% 2.99% 3.08%
CAPEX / EBITDA (%) 8.23% 7.16% 13.18% 14.42% 7.61% 7.09% 7.73% 8.36%
CAPEX / FCF (%) 11.81% 11.04% 16.35% 22.34% 10.19% 11.32% 11.47% 12.07%

Items per share

        
Cash flow per share 1 10.91 11.72 10.39 10.94 13.65 17.47 17.08 17.28
Change - 7.38% -11.36% 5.33% 24.81% 27.97% -2.24% 1.19%
Dividend per Share 1 1.2 1.2 1.2 1.4 1.4 1.535 1.555 1.655
Change - 0% 0% 16.67% 0% 9.63% 1.33% 6.39%
Book Value Per Share 1 33.33 - 45.64 49.89 51.73 61.11 72.01 82.94
Change - - - 9.32% 3.69% 18.13% 17.83% 15.19%
EPS 1 7.76 7.81 7.73 4.15 5.32 12.02 12.12 11.7
Change - 0.64% -1.02% -46.31% 28.19% 125.93% 0.87% -3.52%
Nbr of stocks (in thousands) 82,243 82,380 82,599 82,700 82,100 81,990 81,990 81,990
Announcement Date 11/02/22 09/02/23 08/02/24 13/02/25 12/02/26 - - -
1EUR
Estimates
2026 *2027 *
P/E 11.9x 11.8x
PBR 2.34x 1.98x
EV / Sales 2.27x 2.02x
Yield 1.08% 1.09%

EPS & Dividend

EPS & Dividend - Ipsen


Y-o-Y evolution of P/E

Valuation ratios - P/E - Ipsen
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - Ipsen
Trader
Investor
Global
Quality
ESG MSCI
AA
Ratings Surperformance© - Ipsen
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
142.70EUR
Average target price
164.29EUR
Spread / Average Target
+15.13%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Ipsen